跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEPO-NISOLONE methylprednisolone acetate 40 mg/1 mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
DEPO-NISOLONE methylprednisolone acetate 40 mg/1 mL injection vial
Approved
STANDARD
DEPO-NISOLONE methylprednisolone acetate 40 mg/1 mL injection vial
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
c1e1fe126af56fb0
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
c1e1fe126af56fb0
Product Name
DEPO-NISOLONE methylprednisolone acetate 40 mg/1 mL injection vial
Artg Id
59388
Artg Name
DEPO-NISOLONE methylprednisolone acetate 40 mg/1 mL injection vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1997-04-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4be0a33cf4ea96a0a14cd8519a8285af.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/89aeb3052fb8c3a485ff6a816bbd29ca.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
c1e1fe126af56fb0
Type
Standard
Back to TGA Approvals